Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Agostinelli

Showing results (191-200 of 195) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 195 results.
The Lancet. Haematology|October 4, 2016
The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort studyClaudio Agostinelli, Andrea Gallamini, Luisa Stracqualursi, et al.
Blood|September 29, 2019
Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistryCatalina Amador, Timothy C Greiner, Tayla B Heavican, et al.
The Journal of Experimental Medicine|August 15, 2012
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone developmentDavide Rossi, Vladimir Trifonov, Marco Fangazio, et al.
Hematological Oncology|July 19, 2022
NR1H3 (LXRα) is associated with pro-inflammatory macrophages, predicts survival and suggests potential therapeutic rationales in diffuse large b-cell lymphomaMaria Carmela Vegliante, Saveria Mazzara, Gian Maria Zaccaria, et al.
Nature Communications|January 7, 2023
Dysregulation of PRMT5 in chronic lymphocytic leukemia promotes progression with high risk of Richter's transformationZachary A Hing, Janek S Walker, Ethan C Whipp, et al.
Pageof 20

Showing results (191-200 of 195) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 195 results.
The Lancet. Haematology|October 4, 2016
The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort studyClaudio Agostinelli, Andrea Gallamini, Luisa Stracqualursi, et al.
Blood|September 29, 2019
Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistryCatalina Amador, Timothy C Greiner, Tayla B Heavican, et al.
The Journal of Experimental Medicine|August 15, 2012
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone developmentDavide Rossi, Vladimir Trifonov, Marco Fangazio, et al.
Hematological Oncology|July 19, 2022
NR1H3 (LXRα) is associated with pro-inflammatory macrophages, predicts survival and suggests potential therapeutic rationales in diffuse large b-cell lymphomaMaria Carmela Vegliante, Saveria Mazzara, Gian Maria Zaccaria, et al.
Nature Communications|January 7, 2023
Dysregulation of PRMT5 in chronic lymphocytic leukemia promotes progression with high risk of Richter's transformationZachary A Hing, Janek S Walker, Ethan C Whipp, et al.
Pageof 20